Katsuyuki Keino

Title: Katsuyuki Keino: Innovator in Pharmaceutical Chemistry

Introduction

Katsuyuki Keino is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with antitumor activity. With a total of six patents to his name, his work has had a considerable impact on medical research and drug development.

Latest Patents

One of his latest patents is for a method of making the tetrapeptide derivative TZT-1027 crystal. This invention provides crystals of N-(N,N-dimethyl-L-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide or salts thereof, which possess potent antitumor activity and methods for their preparation. Another notable patent involves substituted pyrazole compounds, which are represented by a specific formula and have shown excellent p38MAP kinase inhibiting effects. These compounds are useful in the prevention or treatment of various diseases related to tumor necrosis factor α, interleukins, and cyclooxygenase II.

Career Highlights

Katsuyuki Keino has worked with notable companies such as Teikoku Hormone Manufacturing Co., Ltd. and Teikoju Hormone Manufacturing Co., Ltd. His career has been marked by a commitment to advancing pharmaceutical innovations that address critical health challenges.

Collaborations

Throughout his career, Keino has collaborated with esteemed colleagues, including Nobuyoshi Minami and Arihiro Kanada. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.

Conclusion

Katsuyuki Keino's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the development of antitumor therapies. His work continues to influence the landscape of medical research and drug development.